Keyphrases
Acetylsalicylic Acid
14%
Anticoagulant Use
14%
Antiplatelet Agents
14%
Antiplatelet Drugs
28%
Antiplatelet Treatment
14%
Antithrombotic Therapy
100%
Asia
42%
Atrial Fibrillation
42%
Baseline Characteristics
14%
Baseline Data
28%
CHA2DS2-VASc
28%
Concomitant Diseases
14%
Concomitant Medications
14%
Congestive Heart Failure
14%
Dabigatran
14%
Descriptive Statistics
14%
Disease Pattern
14%
East Africa
14%
Europe
42%
GLORIA-AF
100%
High Stroke Risk
14%
Hypertension
14%
International Registry
42%
Latin America (LATAM)
14%
Medical Outcomes
14%
Middle East
14%
Moderate Risk
14%
Newly Diagnosed
28%
Non-valvular Atrial Fibrillation
28%
Non-vitamin K Antagonist Oral Anticoagulants
100%
North America
57%
Oral Anticoagulants
14%
Previous Stroke
14%
Sectional Analysis
14%
Stroke Risk
14%
Treatment Patterns
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Undertreated
14%
Vascular Disease
14%
Vitamin K Antagonists
85%
Medicine and Dentistry
Acetylsalicylic Acid
6%
Antiplatelet
6%
Antiplatelet Drug
20%
Antithrombotic
100%
Apoplexy
20%
Atrial Fibrillation
33%
CHA2DS2-VASc Score
13%
Congestive Heart Failure
6%
Cross Sectional Study
6%
Dabigatran
6%
Diabetes Mellitus
6%
Diseases
13%
Oral
13%
Vascular Disease
6%
Vitamin K Antagonist
86%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
6%
Anticoagulant Agent
100%
Antiplatelet
6%
Antithrombocytic Agent
20%
Antivitamin K
86%
Atrial Fibrillation
33%
Cerebrovascular Accident
20%
Congestive Heart Failure
6%
Cross Sectional Study
6%
Dabigatran
6%
Diabetes Mellitus
6%
Diseases
13%
Vascular Disease
6%